Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/29/2854696/0/en/Adlai-Nortye-Announces-Appointment-of-Dr-Archie-Tse-as-the-Head-of-Research-Development.html
https://www.globenewswire.com//news-release/2023/11/17/2782524/0/en/Adlai-Nortye-Announces-Completion-of-Patient-Enrollment-in-Global-Phase-III-Clinical-Trial-of-Buparlisib-AN2025-in-Combination-with-Paclitaxel-for-the-Treatment-of-Recurrent-or-Met.html
https://www.globenewswire.com//news-release/2023/10/23/2764705/0/en/Adlai-Nortye-Ltd-Nucleai-awarded-ESMO-2023-BEST-Poster-Award.html
https://www.globenewswire.com//news-release/2023/10/03/2753988/0/en/Adlai-Nortye-Ltd-Announces-Closing-of-Initial-Public-Offering.html
https://www.globenewswire.com//news-release/2023/09/29/2751764/0/en/Adlai-Nortye-Ltd-Announces-Pricing-of-Initial-Public-Offering.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-partner-adlai-nortye-advances-chinese-bridging-trial-of-pelareorep-paclitaxel-combination-treatment-in-breast-cancer-to-final-dosing-cohort-301509468.html
https://www.prnewswire.com/news-releases/adlai-nortye-announces-appointment-of-dr-victoria-demby-as-senior-vice-president-of-global-regulatory-affairs-301502011.html
https://www.prnewswire.com/news-releases/adlai-nortye-announces-publication-of-preclinical-research-of-an3025-anti-htnfr2in-frontiers-in-immunology-301486211.html
https://www.prnewswire.com/news-releases/adlai-nortye-announces-global-license-out-agreement-with-biotime-for-several-products-including-pd-l1-inhibitor-an4005-and-anti-htnfr2-antibody-an3025-301468390.html
https://www.prnewswire.com/news-releases/oncolytics-biotechpartner-adlai-nortye-doses-first-patient-in-chinese-bridging-trial-evaluating-pelareorep-paclitaxel-combination-treatment-in-breast-cancer-301400289.html